We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.6B
AUM Growth
+$2.65B
(+12%)
Cap. Flow
-$1.17B
Cap. Flow
% of AUM
-4.57%
Top 10 Holdings %
Top 10 Hldgs %
14.38%
Holding
1,445
New
151
Increased
481
Reduced
509
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$56.6M |
| 2 |
Fidelity National Information Services
FIS
|
+$53M |
| 3 |
Advanced Micro Devices
AMD
|
+$48.1M |
| 4 |
RTX Corp
RTX
|
+$43.3M |
| 5 |
Analog Devices
ADI
|
+$38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$72.1M |
| 2 |
PepsiCo
PEP
|
+$70.8M |
| 3 |
American Express
AXP
|
+$70.7M |
| 4 |
Automatic Data Processing
ADP
|
+$49.7M |
| 5 |
Synchrony
SYF
|
+$47.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.67% |
| 2 | Healthcare | 15.33% |
| 3 | Consumer Discretionary | 10% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRC
476
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.65M | 0.03% |
81,695
-36,405
| -31% | -$3.67M |
|
477
UGI
UGI
$8.11B
| $8.61M | 0.03% |
155,400
+22,878
| +17% | +$1.25M |
|
478
Capital One
COF
$127B
| $8.57M | 0.03% |
104,923
-411,334
| -80% | -$33.4M |
|
479
XPO
XPO
$20.9B
| $8.55M | 0.03% |
459,815
+14,728
| +3% | +$283K |
|
480
Arista Networks
ANET
$243B
| $8.46M | 0.03% |
430,224
-42,928
| -9% | -$681K |
|
481
Ball Corp
BALL
$16.1B
| $8.45M | 0.03% |
146,002
+78,796
| +117% | +$4.2M |
|
482
Urban Edge Properties
UE
$2.55B
| $8.44M | 0.03% |
444,175
-217,529
| -33% | -$4.2M |
|
483
Crown Castle
CCI
$31.2B
| $8.44M | 0.03% |
65,907
-2,291
| -3% | -$269K |
|
484
Las Vegas Sands
LVS
$26.7B
| $8.42M | 0.03% |
138,074
+7,932
| +6% | +$467K |
|
485
Marriott International
MAR
$87.9B
| $8.39M | 0.03% |
67,100
+13,476
| +25% | +$1.59M |
|
486
Philip Morris
PM
$303B
| $8.39M | 0.03% |
94,898
-7,513
| -7% | -$605K |
|
487
Allegion
ALLE
$13.1B
| $8.24M | 0.03% |
90,834
+231
| +0.3% | +$20.1K |
|
488
Nexstar Media Group
NXST
$5.2B
| $8.24M | 0.03% |
76,000
+62,000
| +443% | +$5.72M |
|
489
Baker Hughes
BKR
$56.3B
| $8.2M | 0.03% |
295,800
+198,187
| +203% | +$5.01M |
|
|
GWPH
490
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $8.2M | 0.03% |
48,644
| – | – |
|
491
Idexx Laboratories
IDXX
$40.2B
| $8.19M | 0.03% |
36,624
-1,847
| -5% | -$381K |
|
492
Canadian Pacific Kansas City
CP
$78.3B
| $8.16M | 0.03% |
198,045
-32,500
| -14% | -$1.3M |
|
493
Diamondback Energy
FANG
$59.2B
| $8.16M | 0.03% |
80,324
+2,770
| +4% | +$284K |
|
494
TC Energy
TRP
$63.6B
| $8.04M | 0.03% |
178,788
+147,361
| +469% | +$6.33M |
|
495
Bloomin' Brands
BLMN
$686M
| $7.99M | 0.03% |
390,800
+800
| +0.2% | +$15.9K |
|
496
Moody's
MCO
$80.9B
| $7.97M | 0.03% |
44,037
-11,587
| -21% | -$1.9M |
|
497
Integer Holdings
ITGR
$4.29B
| $7.96M | 0.03% |
105,500
-4,700
| -4% | -$385K |
|
498
United Therapeutics
UTHR
$21.5B
| $7.96M | 0.03% |
67,800
+10,712
| +19% | +$1.25M |
|
499
Universal Health Services
UHS
$10.4B
| $7.96M | 0.03% |
59,468
-87,204
| -59% | -$11.5M |
|
|
MASI
500
DELISTED
Masimo
MASI
| $7.94M | 0.03% |
57,436
+9,969
| +21% | +$1.25M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2019 Portfolio in Review
As of Q1 2019, Axa held 1,445 positions worth $25.6B, up 12% from $22.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Axa withdrew a net $1.17B in Q1 2019, closing 137 positions and reducing 509 holdings. Its most notable exit was Newfield Exploration, an estimated $15.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in BlackBerry worth $40.1M.
- Axa's largest Q1 2019 buy was BlackBerry: 3,971,844 shares worth $40.1M.
- Axa added most to Gilead Sciences in Q1 2019, an estimated $56.6M increase.
- Axa's biggest Q1 2019 reduction was Humana, cutting an estimated $72.1M.
- Axa fully exited Newfield Exploration in Q1 2019, selling an estimated $15.3M.
- Axa's ten largest holdings make up 14% of its $25.6B portfolio in Q1 2019.
- Axa opened 151 new positions and closed 137 in Q1 2019.
- Axa's portfolio value rose 12% quarter-over-quarter to $25.6B.
Based on Axa's 13F filing for Q1 2019, filed 14 May 2019.